Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• Basic fibroblast growth factor (FGF2) plays a role in cellular processes.
• Oligonucleotides are investigated for their potential to modulate biological functions.
• Standard phosphodiester oligonucleotides exhibit limited inhibitory effects.

Purpose of the Study:

• To evaluate the inhibitory potential of different oligonucleotide modifications on FGF2 binding.
• To compare the efficacy of phosphorothioate oligonucleotides with standard oligonucleotides and heparin.
• To understand the role of oligonucleotide sequence in modulating FGF2 binding inhibition.

Main Methods:

• Treatment of cells with various oligonucleotides (phosphodiester and phosphorothioate).
• Assay of basic fibroblast growth factor binding to cells.
• Analysis of the impact of oligonucleotide sequence variations on inhibitory activity.

Main Results:

• Phosphorothioate oligonucleotides demonstrated significant inhibition of FGF2 binding.
• Inhibition levels by phosphorothioate oligonucleotides were comparable to the polyanion heparin.
• Oligonucleotide sequence variations influenced the degree of FGF2 binding inhibition.

Conclusions:

• Phosphorothioate oligonucleotides are potent inhibitors of basic fibroblast growth factor binding.
• The mechanism of action for some antisense oligonucleotides may involve FGF2 inhibition.
• Sequence-dependent inhibition by phosphorothioate oligonucleotides is a critical factor in biological systems.